| Serial Number | 98464831 |
| Word Mark | PROSTATE CARE |
| Filing Date | Saturday, March 23, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Wednesday, October 2, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Diagnostic biomarkers for in vitro testing for medical use |
| Goods and Services | Medical diagnosis of Cancer |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 23, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 23, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Pangea Laboratory LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Tustin, CA 92656 |
| Event Date | Event Description |
| Sunday, March 24, 2024 | NEW APPLICATION ENTERED |
| Monday, July 8, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 1, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, October 2, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, October 2, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, October 2, 2024 | NON-FINAL ACTION WRITTEN |